United States· US:69932-001_2f9c7d6f-7f0f-f9dd-e063-6294a90abf59
Axumin
A medicinal product containing fluciclovine f-18, registered in United States by Blue Earth Diagnostics.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLUCICLOVINE F-18
- Manufacturer
- Blue Earth Diagnostics
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11699320013030 mL in 1 VIAL, MULTI-DOSE (69932-001-30)
- ndc11699320015050 mL in 1 VIAL, MULTI-DOSE (69932-001-50)
- ndc1169932-001-30
- ndc1169932-001-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluciclovine f-18 in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAXUMINBlue Earth Diagnostics Ireland Ltd, Dublin
- SwedenAxumin 1600 MBq/ml Injektionsvätska, lösningBlue Earth Diagnostics Ireland Ltd
- NorwayAxuminBlue Earth Diagnostics Ireland Ltd
- BelgiumRadelumin 1300 MBq/mlAbx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien
- FinlandAxuminBlue Earth Diagnostics Ireland Ltd
- FranceAXUMIN 1600 MBq/mL, solution injectableBLUE EARTH DIAGNOSTICS (ROYAUME UNI)
- IrelandAxumin 1,600 MBq/mL solution for injectionBlue Earth Diagnostics Ireland Ltd
- NetherlandsAxumin 1600 MBq/ml oplossing voor injectieBlue Earth Diagnostics Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Radelumin
- Belgium · Radelumin
- Germany · Radelumin
- Spain · Radelumin
- France · Radelumin
- Greece · Próstalumin
- Iceland · Axumin
- Italy · Radelumin
- Liechtenstein · Axumin
- Luxembourg · Radelumin
- Netherlands · Radelumin
- Norway · Axumin
- Poland · Radelumin
- Portugal · Radelumin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0d4dc852-16b0-4b7e-9041-148fb2a41bac GET /v1/drugs/0d4dc852-16b0-4b7e-9041-148fb2a41bac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "221",
"substance": "FLUCICLOVINE F-18",
"productndc": "69932-001",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA208054",
"marketing_category": "NDA"
}See everything about fluciclovine f-18.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.